We can’t show the full text here under this license.
Rapamycin slows age-related DNA changes in skin cells without affecting their growth or development
Updated
Abstract
Epigenetic ageing is not influenced by replicative senescence, telomere length, or cellular proliferation.
- Epigenetic ageing appears to operate independently of traditional markers of cellular ageing.
- Rapamycin, an inhibitor of the mTOR complex, is associated with a reduction in the rate of epigenetic ageing.
- Cellular metabolism may influence both cellular senescence and epigenetic ageing through distinct pathways.
- A validated assay in humans can measure epigenetic ageing and may help identify potential interventions.
Simplified